NewLead Holdings Ltd (NASDAQ:NEWL)’s shares fell 1.38% to $3.46. The company on May 19 announced that the “Newlead Albion”, a 2012-built dry-bulk eco-type Handysize vessel of 32,318 dwt, was delivered to NewLead’s fleet on Monday, May 19, 2014. The Newlead Albion is one of the two eco-type vessels that the Company agreed to acquire in March 2014, as previously announced, for a total acquisition price of $37.0 million, $18.5 million each. At Present, the market value of these vessels is estimated to be approximately $20.25 million each. The second vessel is expected to be delivered to NewLead’s fleet, as scheduled, in July 2014. NewLead Holdings Ltd (NASDAQ:NEWL) weekly performance is 349.21%. On last trading day company shares ended up $2.83. NewLead Holdings Ltd (NASDAQ:NEWL) distance from 50-day simple moving average (SMA50) is -93.04 1.00%.
India Globalization Capital, Inc. (NYSEMKT:IGC) slumped -20.00% following possible profit taking by investors as the stock was surging a day before after Indian president Pranab Mukherjee appointed Narendra Modi as the new Prime Minister of the nation. Modi will succeed Manmohan Singh, whose Congress party suffered its worst defeat in history in India’s recent general elections. Mukherjee will administer the oath of office and secrecy to Modi on May 26. India Globalization Capital, Inc. (NYSEMKT:IGC) shares fell -17.50% in last trading session and ended the day on $1.32 . Gross Margin is 18.40% and its return on assets is -18.20%. India Globalization Capital, Inc. (NYSEMKT:IGC) quarterly performance is 60.98%.
Atossa Genetics Inc. (NASDAQ:ATOS) announced that its Board of Directors has approved the adoption of a stockholder rights agreement. The stockholder rights agreement is designed to deter coercive, unfair, or inadequate takeovers and other abusive tactics that might be used in an attempt to gain control of Atossa without paying all stockholders a fair price for their shares. The stockholder rights agreement will not prevent takeovers at a full and fair price, but is designed to deter coercive takeover tactics and to encourage anyone attempting to acquire Atossa to first negotiate with the Board of Directors. Atossa Genetics Inc (NASDAQ:ATOS) shares moved down -18.85% in last trading session and was closed at $1.55, while trading in range of $1.52 – $1.90. Atossa Genetics Inc (NASDAQ:ATOS) year to date (YTD) performance is -33.19%.
On May 13, Royale Energy, Inc. (NASDAQ:ROYL) announced results for first quarter 2014, showing an improvement of 38% over the same period in 2013. Losses decreased from $1,234,474 ($0.10 per share) to $767,105 ($0.05 per share), an improvement of $467,369 for the quarter. Oil and Natural Gas Revenue, for the first quarter, grew by 150%, from $330,895 in 2013 to $825,556 in 2014. The increased revenue is a result of improved production and price. Production increased 66% to 150,000 MCFE, while the average price rose 55% over a year ago to $5.39 per MCF. General & Administrative expenses remained low, decreasing from $860,013 to $835,061 respectively. Royale Energy, Inc. (NASDAQ:ROYL) ended the last trading day at $3.11. Company weekly volatility is calculated as 9.51% and price to cash ratio as 9.49. Royale Energy, Inc. (NASDAQ:ROYL) showed a positive weekly performance of 10.68%.
OXiGENE, Inc. (NASDAQ:OXGN) a biopharmaceutical company developing novel cancer therapeutics, announced that it has entered into definitive agreements with institutional investors to purchase an aggregate of $16 million of registered shares of OXiGENE common stock in an at-the-market direct offering at $ 2.9625 per share. For each share of common stock purchased, investors will receive one-half of an unregistered warrant to purchase a share of common stock at an exercise price of $2.90 per share, which are exercisable immediately and expire five years and three months from the date of issuance. The closing of the offering is expected to take place on or about May 28, 2014, subject to the satisfaction of customary closing conditions. OXiGENE Inc (NASDAQ:OXGN) weekly performance is -11.73%. On last trading day company shares ended up $2.71. Analysts mean target price for the company is $7.50. OXiGENE Inc (NASDAQ:OXGN) distance from 50-day simple moving average (SMA50) is -17.68%.
Leave a Reply